Blue Owl Capital has slashed the value of its loans to manufacturer Loparex to near zero, triggering immediate valuation concerns across the 1.8 trillion dollar private credit sector. While default risks have spurred increased scrutiny and a Hold rating from Seeking Alpha Quant, Blue Owl continues to support an 18.3 billion dollar market cap and a 7.7 percent dividend yield. Investors are closely monitoring whether this massive loan write-down represents an isolated failure or an early indicator of widespread stress in direct lending portfolios.
|
John Stankey, AT&T chairman and CEO, tal...
The Rams will play in the NFL’s first-ev...
Shad Khan, Jacksonville Jaguars owner, j...
Apple unveiled new products at its annua...
On today’s Big Take Asia podcast: How In...
Crowdstrike Founder and CEO George Kurtz...
Apple unveiled the company’s first folda...
Live from Apple Park, Nilay Patel and Vi...
Is Oscar Health ($OSCR) a health insurer...
Bloomberg’s Ed Ludlow is live from Apple...